33841013|t|20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis.
33841013|a|BACKGROUND: Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders. Enhancing hippocampal neurogenesis by promoting proliferation and differentiation of neural stem cells (NSCs) is a promising therapeutic strategy for AD. 20(S)-protopanaxadiol (PPD) and oleanolic acid (OA) are small, bioactive compounds found in ginseng that can promote NSC proliferation and neural differentiation in vitro. However, it is currently unknown whether PPD or OA can attenuate cognitive deficits by enhancing hippocampal neurogenesis in vivo in a transgenic APP/PS1 AD mouse model. Here, we administered PPD or OA to APP/PS1 mice and monitored the effects on cognition and hippocampal neurogenesis. METHODS: We used the Morris water maze, Y maze, and open field tests to compare the cognitive capacities of treated and untreated APP/PS1 mice. We investigated hippocampal neurogenesis using Nissl staining and BrdU/NeuN double labeling. NSC proliferation was quantified by Sox2 labeling of the hippocampal dentate gyrus. We used western blotting to determine the effects of PPD and OA on Wnt/GSK3beta/beta-catenin pathway activation in the hippocampus. RESULTS: Both PPD and OA significantly ameliorated the cognitive impairments observed in untreated APP/PS1 mice. Furthermore, PPD and OA significantly promoted hippocampal neurogenesis and NSC proliferation. At the mechanistic level, PPD and OA treatments resulted in Wnt/GSK-3beta/beta-catenin pathway activation in the hippocampus. CONCLUSION: PPD and OA ameliorate cognitive deficits in APP/PS1 mice by enhancing hippocampal neurogenesis, achieved by stimulating the Wnt/GSK-3beta/beta-catenin pathway. As such, PPD and OA are promising novel therapeutic agents for the treatment of AD and other neurodegenerative diseases.
33841013	0	21	20(S)-protopanaxadiol	Chemical	MESH:C062916
33841013	26	40	oleanolic acid	Chemical	MESH:D009828
33841013	52	70	cognitive deficits	Disease	MESH:D003072
33841013	78	81	PS1	Gene	19164
33841013	93	97	mice	Species	10090
33841013	149	168	Alzheimer's disease	Disease	MESH:D000544
33841013	170	172	AD	Disease	MESH:D000544
33841013	203	230	neurodegenerative disorders	Disease	MESH:D019636
33841013	382	384	AD	Disease	MESH:D000544
33841013	386	407	20(S)-protopanaxadiol	Chemical	MESH:C062916
33841013	409	412	PPD	Chemical	MESH:C062916
33841013	418	432	oleanolic acid	Chemical	MESH:D009828
33841013	434	436	OA	Chemical	MESH:D009828
33841013	478	485	ginseng	Species	4054
33841013	599	602	PPD	Chemical	MESH:C062916
33841013	606	608	OA	Chemical	MESH:D009828
33841013	623	641	cognitive deficits	Disease	MESH:D003072
33841013	708	711	PS1	Gene	19164
33841013	712	714	AD	Disease	MESH:D000544
33841013	715	720	mouse	Species	10090
33841013	750	753	PPD	Chemical	MESH:C062916
33841013	757	759	OA	Chemical	MESH:D009828
33841013	767	770	PS1	Gene	19164
33841013	771	775	mice	Species	10090
33841013	979	982	PS1	Gene	19164
33841013	983	987	mice	Species	10090
33841013	1060	1064	NeuN	Gene	52897
33841013	1118	1122	Sox2	Gene	20674
33841013	1219	1222	PPD	Chemical	MESH:C062916
33841013	1227	1229	OA	Chemical	MESH:D009828
33841013	1237	1245	GSK3beta	Gene	56637
33841013	1246	1258	beta-catenin	Gene	12387
33841013	1312	1315	PPD	Chemical	MESH:C062916
33841013	1320	1322	OA	Chemical	MESH:D009828
33841013	1353	1374	cognitive impairments	Disease	MESH:D003072
33841013	1401	1404	PS1	Gene	19164
33841013	1405	1409	mice	Species	10090
33841013	1424	1427	PPD	Chemical	MESH:C062916
33841013	1432	1434	OA	Chemical	MESH:D009828
33841013	1532	1535	PPD	Chemical	MESH:C062916
33841013	1540	1542	OA	Chemical	MESH:D009828
33841013	1570	1579	GSK-3beta	Gene	56637
33841013	1580	1592	beta-catenin	Gene	12387
33841013	1644	1647	PPD	Chemical	MESH:C062916
33841013	1652	1654	OA	Chemical	MESH:D009828
33841013	1666	1684	cognitive deficits	Disease	MESH:D003072
33841013	1692	1695	PS1	Gene	19164
33841013	1696	1700	mice	Species	10090
33841013	1772	1781	GSK-3beta	Gene	56637
33841013	1782	1794	beta-catenin	Gene	12387
33841013	1813	1816	PPD	Chemical	MESH:C062916
33841013	1821	1823	OA	Chemical	MESH:D009828
33841013	1884	1886	AD	Disease	MESH:D000544
33841013	1897	1923	neurodegenerative diseases	Disease	MESH:D019636
33841013	Negative_Correlation	MESH:D009828	MESH:D019636
33841013	Negative_Correlation	MESH:C062916	MESH:D019636
33841013	Positive_Correlation	MESH:C062916	12387
33841013	Association	MESH:D003072	12387
33841013	Negative_Correlation	MESH:C062916	MESH:D003072
33841013	Association	MESH:D003072	56637
33841013	Negative_Correlation	MESH:D009828	MESH:D003072
33841013	Positive_Correlation	MESH:C062916	56637
33841013	Positive_Correlation	MESH:D009828	56637
33841013	Positive_Correlation	MESH:D009828	12387
33841013	Association	12387	56637

